These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 21687773)

  • 21. Line bisection in Parkinson's disease: investigation of contributions of visual field, retinal vision, and scanning patterns to visuospatial function.
    Laudate TM; Neargarder S; Cronin-Golomb A
    Behav Neurosci; 2013 Apr; 127(2):151-63. PubMed ID: 23356329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colour-centred Release Hallucinations in a Patient with Early Parkinson's Disease and Unrecognised Autosomal Dominant Optic Atrophy.
    Hardwick M; Heath D; Saha R; Cooper S
    Neuroophthalmology; 2021; 45(4):273-276. PubMed ID: 34366517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual hallucinosis: the major clinical determinant of distorted chromatic contour perception in Parkinson's disease.
    Büttner T; Kuhn W; Müller T; Welter FL; Federlein J; Heidbrink K; Przuntek H
    J Neural Transm (Vienna); 1996; 103(10):1195-204. PubMed ID: 9013406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ophthalmological and electrophysiological features of Parkinson's disease.
    Nowacka B; Lubiński W; Karczewicz D
    Klin Oczna; 2010; 112(7-9):247-52. PubMed ID: 21117366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of optic flow perception and egocentric coordinates on veering in Parkinson's disease.
    Davidsdottir S; Wagenaar R; Young D; Cronin-Golomb A
    Brain; 2008 Nov; 131(Pt 11):2882-93. PubMed ID: 18957454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereopsis and Eye Movement Abnormalities in Parkinson's Disease and Their Clinical Implications.
    Ba F; Sang TT; He W; Fatehi J; Mostofi E; Zheng B
    Front Aging Neurosci; 2022; 14():783773. PubMed ID: 35211005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous VEP and PERG investigations in early Parkinson's disease.
    Calzetti S; Franchi A; Taratufolo G; Groppi E
    J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):114-7. PubMed ID: 2313297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual exploration of emotional facial expressions in Parkinson's disease.
    Clark US; Neargarder S; Cronin-Golomb A
    Neuropsychologia; 2010 Jun; 48(7):1901-13. PubMed ID: 20230847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visual alterations in de novo Parkinson's disease: pattern electroretinogram latencies are more delayed and more reversible by levodopa than are visual evoked potentials.
    Peppe A; Stanzione P; Pierelli F; De Angelis D; Pierantozzi M; Bernardi G
    Neurology; 1995 Jun; 45(6):1144-8. PubMed ID: 7783879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do people with Parkinson's disease look at task relevant stimuli when walking? An exploration of eye movements.
    Hunt D; Stuart S; Nell J; Hausdorff JM; Galna B; Rochester L; Alcock L
    Behav Brain Res; 2018 Aug; 348():82-89. PubMed ID: 29559336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclinical visuospatial impairment in Parkinson's disease: the role of Basal Ganglia and limbic system.
    Caproni S; Muti M; Di Renzo A; Principi M; Caputo N; Calabresi P; Tambasco N
    Front Neurol; 2014; 5():152. PubMed ID: 25157239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual and spatial symptoms in Parkinson's disease.
    Davidsdottir S; Cronin-Golomb A; Lee A
    Vision Res; 2005 May; 45(10):1285-96. PubMed ID: 15733961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson's disease (PD).
    Nowacka B; Lubiński W; Honczarenko K; Potemkowski A; Safranow K
    Doc Ophthalmol; 2015 Oct; 131(2):95-104. PubMed ID: 25972299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Slower saccadic reading in Parkinson's disease.
    Jehangir N; Yu CY; Song J; Shariati MA; Binder S; Beyer J; Santini V; Poston K; Liao YJ
    PLoS One; 2018; 13(1):e0191005. PubMed ID: 29364897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visuospatial functioning is associated with sleep disturbance and hallucinations in nondemented patients with Parkinson's disease.
    Specketer K; Zabetian CP; Edwards KL; Tian L; Quinn JF; Peterson-Hiller AL; Chung KA; Hu SC; Montine TJ; Cholerton BA
    J Clin Exp Neuropsychol; 2019 Oct; 41(8):803-813. PubMed ID: 31177941
    [No Abstract]   [Full Text] [Related]  

  • 37. Visual signs and symptoms of multiple system atrophy.
    Armstrong RA
    Clin Exp Optom; 2014 Nov; 97(6):483-91. PubMed ID: 25256122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.
    Lee AH; Weintraub D
    Mov Disord; 2012 Jun; 27(7):858-63. PubMed ID: 22674352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual dysfunction, neurodegenerative diseases, and aging.
    Jackson GR; Owsley C
    Neurol Clin; 2003 Aug; 21(3):709-28. PubMed ID: 13677819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual Hallucinations Are Characterized by Impaired Sensory Evidence Accumulation: Insights From Hierarchical Drift Diffusion Modeling in Parkinson's Disease.
    O'Callaghan C; Hall JM; Tomassini A; Muller AJ; Walpola IC; Moustafa AA; Shine JM; Lewis SJG
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2017 Nov; 2(8):680-688. PubMed ID: 29560902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.